Shareholders’ Equity (Tables)
|
12 Months Ended |
Dec. 31, 2024 |
|---|
| Shareholders’ Equity [Abstract] |
|
| Schedule of Significant Inputs into Black-Scholes Valuation Model |
The
significant inputs into the Black-Scholes valuation model at the initial recognition date are as follows: | |
| 5.5 Years
June
Warrants |
|
| 2 Years
June
Warrants |
|
| Term |
| |
5.5 years |
|
| |
2 years |
|
| Dividend |
| |
- |
|
| |
- |
|
| Expected volatility |
| |
44.77 |
% |
| |
44.77 |
% |
| Risk-free rate |
| |
3.95 |
% |
| |
4.28 |
% |
| Stock price |
| $ |
1.97 |
|
| $ |
1.97 |
|
| |
| 2 Years
July
Warrants |
|
| Term |
| |
2 years |
|
| Dividend |
| |
- |
|
| Expected volatility |
| |
61.60 |
% |
| Risk-free rate |
| |
3.86 |
% |
| Stock price |
| $ |
1.65 |
|
|
| Schedule of Outstanding Warrants |
Total outstanding warrants as of
December 31,2024, are as follow:
| |
|
Number of
warrants |
|
Exercise
price |
|
Period left
in years |
| Warrants May 2023 |
|
66,127 |
|
$4.625 |
|
3.9 |
| Warrants December 2023 |
|
1,360,170 |
|
$1.18 - $1.47 |
|
4.5 |
| Warrants June 2024 |
|
1,069,647 |
|
$2 - $3.43 |
|
5.0 |
| Warrants July 2024 |
|
2,069,317 |
|
$2.5 - $1.75 |
|
1.75 |
| Other |
|
36,792 |
|
$10.27 - $50 |
|
1.50 - 2.4 |
| Outstanding as of December 31, 2024 |
|
4,602,053 |
|
|
|
|
|
| Schedule of Awards Granted |
During the years ended December 31, 2024, and December 2023, the following awards were granted: | Award Type (2015 Plan) | | Number of
Awards in
2024 | | | Number of
Awards in
2023 | | | Vesting Conditions | | Expiration Date |
| Options | | | - | | | | 400 | | | Over 4 years from grant date-25% every year (from the second year- 2.08% each month) | | 10th anniversary of Grant Date |
| RSU | | | - | | | | 45,100 | | | Over 3 years from grant date | | |
|
| Schedule of Information Regarding Number of Ordinary Shares Issuable upon Outstanding Options and Exercisable Options |
A summary of the Company’s share option activity under option plans is as follows: | |
| Number of
Options |
|
| Weighted-
Average
Exercise
Price |
|
| Weighted
Average
Remaining
Contractual
Life |
|
| Outstanding – January 1, 2024 |
| |
87,764 |
|
| $ |
3.63 |
|
| |
4.11 |
|
| Granted |
| |
- |
|
| $ |
- |
|
| |
- |
|
| Exercised |
| |
(22,809 |
) |
| $ |
0.96 |
|
| |
- |
|
| Forfeited |
| |
(2,277 |
) |
| $ |
9.58 |
|
| |
- |
|
| |
| |
|
|
| |
|
|
| |
|
|
| Outstanding – December 31, 2024 |
| |
62,678 |
|
| $ |
4.38 |
|
| |
3.4 |
|
| |
| |
|
|
| |
|
|
| |
|
|
| Exercisable – December 31, 2024 |
| |
59,721 |
|
| $ |
3.56 |
|
| |
2.7 |
|
|
| Schedule of Information Regarding Number of Ordinary Shares Issuable upon Outstanding Options and Exercisable Options |
The following table summarize information as of December 31, 2024, regarding the number of ordinary shares issuable upon outstanding options and exercisable options: | Exercise price |
| Options
outstanding as of
December 31,
2024 |
|
| Weighted
average
remaining
contractual
life (years) |
|
| Options
exercisable as of
December 31,
2024 |
|
| Weighted
average
remaining
contractual
life (years) |
|
| 0.64 |
| |
24,586 |
|
| |
0.61 |
|
| |
24,586 |
|
| |
0.61 |
|
| 1.06 |
| |
25,936 |
|
| |
3.6 |
|
| |
25,936 |
|
| |
3.60 |
|
| 1.48 |
| |
400 |
|
| |
8.71 |
|
| |
200 |
|
| |
8.71 |
|
| 5.78 |
| |
4,000 |
|
| |
5.98 |
|
| |
2500 |
|
| |
4.79 |
|
| 13.62 |
| |
3,894 |
|
| |
6.41 |
|
| |
3,830 |
|
| |
6.41 |
|
| 40.00 |
| |
3,862 |
|
| |
7.69 |
|
| |
2,669 |
|
| |
7.67 |
|
| |
| |
62,678 |
|
| |
|
|
| |
59,721 |
|
| |
|
|
The following table summarize information as of December 31, 2023, regarding the number of ordinary shares issuable upon outstanding options and exercisable options: | Exercise price |
| Options
outstanding as of
December 31,
2023 |
|
| Weighted
average
remaining
contractual
life (years) |
|
| Options
exercisable as of
December 31,
2023 |
|
| Weighted
average
remaining
contractual
life (years) |
|
| 0.64 |
| |
30,309 |
|
| |
1.61 |
|
| |
30,309 |
|
| |
1.61 |
|
| 1.06 |
| |
43,461 |
|
| |
4.44 |
|
| |
43,402 |
|
| |
4.43 |
|
| 1.48 |
| |
400 |
|
| |
9.71 |
|
| |
100 |
|
| |
9.71 |
|
| 5.78 |
| |
5,500 |
|
| |
8.96 |
|
| |
1,750 |
|
| |
8.96 |
|
| 13.62 |
| |
3,894 |
|
| |
7.41 |
|
| |
2,524 |
|
| |
7.41 |
|
| 40.00 |
| |
4,200 |
|
| |
8.72 |
|
| |
1,979 |
|
| |
8.72 |
|
| |
| |
87,764 |
|
| |
|
|
| |
80,064 |
|
| |
|
|
|
| Schedule of Share-based Compensation Expense for Share Options and RSUs |
Share-based compensation expense for share options in the consolidated statements of comprehensive loss is summarized as follows:
| |
|
Year Ended
December 31, |
|
| |
|
2024 |
|
|
2023 |
|
| Cost of revenues |
|
|
2 |
|
|
|
3 |
|
| Research and development |
|
|
4 |
|
|
|
23 |
|
| Sales and marketing |
|
|
2 |
|
|
|
11 |
|
| General and administrative |
|
|
6 |
|
|
|
11 |
|
| Total Share-based compensation expense |
|
|
14 |
|
|
|
48 |
|
Share-based compensation expense for
RSUs in the consolidated statement of comprehensive loss is summarized as follows:
| |
|
Year Ended
December 31 |
|
| |
|
2024 |
|
|
2023 |
|
| |
|
U.S. dollars in thousands |
|
| Cost of revenues |
|
|
10 |
|
|
|
9 |
|
| Research and development |
|
|
18 |
|
|
|
53 |
|
| Sales and marketing |
|
|
36 |
|
|
|
47 |
|
| General and administrative |
|
|
259 |
|
|
|
220 |
|
| Total Share-based compensation expense |
|
|
323 |
|
|
|
329 |
|
|
| Schedule of Awards Granted |
A summary of the Company’s RSUs activity under option
plans is as follows:
| |
|
Year ended
December 31, 2024 |
|
| |
|
Number of
RSUs |
|
|
Weighted-
Average
Grant
Date Fair
Value |
|
| RSUs outstanding at the beginning of the year |
|
|
71,280 |
|
|
$ |
10.35 |
|
| Granted during the year |
|
|
- |
|
|
|
|
|
| Vested during the year |
|
|
(28,228 |
) |
|
|
8.44 |
|
| Forfeited during the year |
|
|
(6,798 |
) |
|
|
7.44 |
|
| Outstanding at the end of the year |
|
|
36,254 |
|
|
$ |
12.38 |
|
|